FDA recall D-1252-2020

Lupin Pharmaceuticals Inc. · Class II · drug

Product

Cefixime for Oral Suspension USP, 100mg/5mL, Rx Only, Manufactured for: Lupin Pharmaceutical, Inc. Baltimore, Maryland 21202 United States, Manufactured by: Lupin Limited Mandideep 462 046 INDIA, NDC 68180-405-01

Reason for recall

Subpotent Drug: low out of specification (OOS) test result observed in long term stability study.

Distribution

Nationwide with the United States and Puerto Rico.

Key facts

Status
Terminated
Initiation date
2020-04-15
Report date
2020-04-29
Termination date
2021-06-07
Voluntary/Mandated
Voluntary: Firm initiated
Location
Baltimore, MD, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1252-2020